Yuka Lee-Harata
North Terrace
Adelaide, SA 5005, Australia
Adelaide, SA 5005, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Target pathway validation for Compound Kushen Injection active against cancer cells.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 28, 2026
Compound Kushen injection reduces severity of radiation-induced gastrointestinal mucositis in rats.
Journal: Frontiers in oncology
Published: April 27, 2022
Corrigendum to "Future directions for the discovery of natural product-derived immunomodulating drugs: An IUPHAR positional review" [Pharmacol. Res. 177 (2022) 106076].
Journal: Pharmacological research
Published: April 16, 2022
Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review.
Journal: Pharmacological research
Published: December 21, 2021
A New Strategy for Identifying Mechanisms of Drug-drug Interaction Using Transcriptome Analysis: Compound Kushen Injection as a Proof of Principle.
Journal: Scientific reports
Published: July 11, 2019
ACKR4 restrains antitumor immunity by regulating CCL21.
Journal: The Journal of experimental medicine
Published: April 09, 2019
An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 21, 2019
Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell Lines.
Journal: Frontiers in oncology
Published: February 14, 2019
Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle.
Journal: Scientific reports
Published: January 16, 2019
Last Updated: 09/26/2026